Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease
Authors
Keywords
Biomarker, Alzheimer’s disease, CSF, p-Tau231
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 126, Issue 3, Pages 339-348
Publisher
Springer Nature
Online
2019-02-14
DOI
10.1007/s00702-019-01982-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia
- (2018) Spomenka Kiđemet-Piskač et al. CNS Neuroscience & Therapeutics
- Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease
- (2018) Jonathan Vogelgsang et al. EXPERIMENTAL BRAIN RESEARCH
- A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
- (2018) Hedieh Shahpasand-Kroner et al. Alzheimers Research & Therapy
- Tau and tauopathies
- (2016) Thomas Arendt et al. BRAIN RESEARCH BULLETIN
- Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort
- (2016) Hans-W. Klafki et al. JOURNAL OF ALZHEIMERS DISEASE
- Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives
- (2016) Mina Park et al. KOREAN JOURNAL OF RADIOLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- The use of PET in Alzheimer disease
- (2010) Agneta Nordberg et al. Nature Reviews Neurology
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Identifying and validating biomarkers for Alzheimer's disease
- (2010) Christian Humpel TRENDS IN BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started